Effects of Acanthopanax senticosus Harms on Anexiety, Motivation to Learn, Sleep Status, and Fatigue Assiciated with Learning Status in University Students

UMIN ID: UMIN000056180

Registered date:18/11/2024

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Healthy subjects
• Date of first enrollment: 2024/06/20
• Target sample size: 32
• Countries of recruitment: Japan
• Study type: Interventional

Intervention(s)

Administration of Acanthopanax senticosus Harms during 12 weeks.
Administration of placebo during 12 weeks.

Outcome(s)

• Primary Outcome: Before Administration, after 1 month, after 2 months 1)Questionnaires about health condition 2)General Self-Efficacy Scale (GSES) 3)OSA Sleep inventory 4)STAI
• Secondary Outcome: Before Administration, after 1 month, after 2 months 1)Salivary Amylase 2)Salivary Cortisol 3)Autonomic activity

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1)Persons who have ingested foods containing Acanthopanax senticosus Harms within 3 months. 2)Persons who comsume health foods or supplements that may affect the study results. 3)Persons with allergies to Acanthopanax senticosus Harms. 4)Persons who are in hospital, on mdication, or undergoing treatment. 5)Persons with alcohol dependence. 6)Persons participating in other clinical studies. 7)Persons with a history of sever hepatic, renal, or cardiac disorders. 8)Persons with pre-existing or current hepatitis. 9)Persons with sever anemia. 10)Persons with hypertension (systolic blood pressure: 180 mmHg or higher, diastolic blood pressure: 90 mmHg or higher). 11)Persons deemed by the principal investigater and sub-investigater to be inappropriate to participate in the study.

Related Information

• Primary Sponsor: Suzuka University of Medicinal Science
• Source(s) of Monetary Support: Suzuka University of Medicinal Science